
Articles
-
1 day ago |
cheddar.com | Peter Green
Forget Brad and Angelina, Ben and Jenn, The Beatles, Brexit, or even Henry VIII and his wives. This is the biggest split in recent history. Donald Trump and Elon Musk have officially ended their bromance, and it looks like it will spell trouble for the house of government-subsidized cards that make up Elon's business empire.
-
1 week ago |
cheddar.com | Peter Green
When uncertainty hits the markets, some people see an opportunity to start trading. Take the latest Wall Street phenomenon, the so-called "TACO trade," for example. Coined by Financial Times reporter Robert Armstrong, the term is short for "Trump Always Chickens Out," and it's a trade to buy stocks that fall when Trump announces punitive tariffs of one kind or another, and then sell them when, a few days later, Trump inevitably backs off on his tariff threat. Volatility, meet trading opportunity.
-
2 weeks ago |
cheddar.com | Peter Green
It's been a bumpy ride for Uber $UBER, which lost billions of dollars under founder Travis Kalanick, subsidizing rides to win users away from traditional taxi and car rental services. But it looks like under the leadership of CEO Dara Khosrowshahi, who arrived in 2017, the ride-hailing app is finally back in the good graces of investors-and riders.
-
3 weeks ago |
cheddar.com | Peter Green
Forget punch cards, forget Charlie Chaplin selling PCs. Forget ThinkPads. All that was sold off years ago. IBM, the company that turned the personal computer and the laptop into household items, has reinvented itself as an AI consulting company, and its stock is booming. Still part of the slower and sturdier Dow Jones Industrial Average (it makes mainframes and quantum computers), IBM's shares are up 20% this year, while the Dow is down half a point since January 1. How did that happen?
-
4 weeks ago |
cheddar.com | Peter Green
CVS has itself covered coming and going: It's not just a retail pharmacy where generics cost twice what they sell for at independent drug stores-it's also a health insurer, a general retailer and, most lucrative of all, a pharmacy benefits manager. Tie all those together, and you have a healthcare conglomerate whose shares are up more than 50% so far this year. Good news, right? Well, kinda.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →